Pfizer to receive $29m from residual SAC Capital insider trading settlement
Pfizer has agreed to accept $29m to resolve a long-running dispute linked to the US Securities and Exchange Commission’s 2013 insider trading settlement with SAC Capital Management, the former hedge fund of Steven A Cohen, according to a report by